Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant risk » significant role (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant risk » significant role (Expand Search)
-
2721
-
2722
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2723
-
2724
-
2725
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2726
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2727
-
2728
-
2729
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2730
-
2731
-
2732
-
2733
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2734
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2735
-
2736
-
2737
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2738
-
2739
-
2740